Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Solute carrier organic anion transporter family member 2A1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | prostaglandin transporter | Get druggable targets OG5_139610 | All targets in OG5_139610 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_139610 | All targets in OG5_139610 |
Onchocerca volvulus | Putative organic anion transporter | Get druggable targets OG5_139610 | All targets in OG5_139610 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | Solute carrier organic anion transporter family | 0.0034 | 0.0295 | 1 |
Onchocerca volvulus | Putative organic anion transporter | 0.0034 | 0.0295 | 0.0219 |
Brugia malayi | sodium-independent organic anion transporter family protein | 0.0034 | 0.0295 | 0.05 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0169 | 0.0287 |
Brugia malayi | Kazal-type serine protease inhibitor domain containing protein | 0.0023 | 0.0169 | 0.0287 |
Echinococcus granulosus | organic anion transporting polypeptide 30B | 0.0034 | 0.0295 | 1 |
Onchocerca volvulus | 0.0034 | 0.0295 | 0.0219 | |
Schistosoma mansoni | agrin | 0.0023 | 0.0169 | 0.5738 |
Loa Loa (eye worm) | hypothetical protein | 0.0087 | 0.0927 | 0.1572 |
Trypanosoma cruzi | MFS transporter, putative | 0.0034 | 0.0295 | 0.5 |
Brugia malayi | hypothetical protein | 0.0034 | 0.0295 | 0.05 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0295 | 0.05 |
Brugia malayi | Kazal-type serine protease inhibitor domain containing protein | 0.0023 | 0.0169 | 0.0287 |
Brugia malayi | secreted modular calcium-binding protein 1 | 0.0023 | 0.0169 | 0.0287 |
Brugia malayi | hypothetical protein | 0.0034 | 0.0295 | 0.05 |
Loa Loa (eye worm) | sodium-independent organic anion transporter | 0.0034 | 0.0295 | 0.05 |
Onchocerca volvulus | Putative organic anion transporter | 0.0034 | 0.0295 | 0.0219 |
Onchocerca volvulus | 0.0034 | 0.0295 | 0.0219 | |
Brugia malayi | Kazal-type serine protease inhibitor domain containing protein | 0.0023 | 0.0169 | 0.0287 |
Schistosoma mansoni | organic anion transporter | 0.0034 | 0.0295 | 1 |
Schistosoma mansoni | follistatin | 0.0023 | 0.0169 | 0.5738 |
Echinococcus multilocularis | expressed protein | 0.0023 | 0.0169 | 0.0169 |
Brugia malayi | prostaglandin transporter | 0.051 | 0.59 | 1 |
Brugia malayi | sodium-independent organic anion transporter family protein | 0.0034 | 0.0295 | 0.05 |
Brugia malayi | Kazal-type serine protease inhibitor domain containing protein | 0.0023 | 0.0169 | 0.0287 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0295 | 0.05 |
Onchocerca volvulus | 0.0034 | 0.0295 | 0.0219 | |
Onchocerca volvulus | Putative organic anion transporter | 0.051 | 0.59 | 1 |
Echinococcus granulosus | follistatin | 0.0023 | 0.0169 | 0.5738 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0169 | 0.0287 |
Echinococcus multilocularis | Solute carrier organic anion transporter family | 0.0034 | 0.0295 | 0.0295 |
Echinococcus multilocularis | organic anion transporting polypeptide 30B | 0.0034 | 0.0295 | 0.0295 |
Echinococcus multilocularis | agrin | 0.0023 | 0.0169 | 0.0169 |
Brugia malayi | sodium-independent organic anion transporter family protein | 0.0034 | 0.0295 | 0.05 |
Toxoplasma gondii | transporter, major facilitator family protein | 0.0034 | 0.0295 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0126 | 0.1386 | 0.2349 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0169 | 0.0287 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0169 | 0.0287 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0295 | 0.05 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0295 | 0.05 |
Echinococcus multilocularis | follistatin | 0.0023 | 0.0169 | 0.0169 |
Onchocerca volvulus | 0.0034 | 0.0295 | 0.0219 | |
Loa Loa (eye worm) | agrin synaptic family protein | 0.0023 | 0.0169 | 0.0287 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0295 | 0.05 |
Entamoeba histolytica | Acid sphingomyelinase-like phosphodiesterase, putative | 0.0087 | 0.0927 | 0.5 |
Loa Loa (eye worm) | kazal-type serine protease inhibitor domain-containing protein | 0.0023 | 0.0169 | 0.0287 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0295 | 0.05 |
Onchocerca volvulus | 0.0034 | 0.0295 | 0.0219 | |
Schistosoma mansoni | organic anion transporter | 0.0034 | 0.0295 | 1 |
Brugia malayi | SPARC precursor | 0.0023 | 0.0169 | 0.0287 |
Loa Loa (eye worm) | hypothetical protein | 0.051 | 0.59 | 1 |
Echinococcus granulosus | agrin | 0.0023 | 0.0169 | 0.5738 |
Entamoeba histolytica | Acid sphingomyelinase-like phosphodiesterase, putative | 0.0087 | 0.0927 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0126 | 0.1386 | 0.2349 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0126 | 0.1386 | 0.2349 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 1380 nM | BindingDB_Patents: Inhibition Assay. MDCK cells stably transfected with rat PGT (Endo et al., 2002) were seeded at 15-20% confluence on 24-well plates. The day on which the cells were seeded was considered day 1. PGE2 uptake experiments were conducted on day 4. All of the PGE2 uptake experiments were conducted at room temperature. On day 4, cells were washed twice with Waymouth buffer (135 mM NaCl, 13 mM H-Hepes, 13 mM Na-Hepes, 2.5 mM CaCl2, 1.2 mM MgCl2, 0.8 mM MgSO4, 5 mM KCl, and 28 mM D-glucose). Then 200 µL of Waymouth buffer containing [3H]PGE2 (purchased from Perkin Elmer) was added to each well. At the designed time, the uptake of [3H]PGE2 was stopped by aspiration of uptake buffer; this was followed by immediate washing twice with 500 µL of chilled Waymouth buffer. Cells were then lysed with 100 µL lysis buffer containing 0.25% SDS and 0.05 N NaOH. 1.5 mL of scintillation solution was added to each well, and intracellular [3H]PGE2 was counted by MicroBeta Counter. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.